343 related articles for article (PubMed ID: 20472718)
1. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.
Shimizu M; Yokoyama T; Yamada K; Kaneda H; Wada H; Wada T; Toma T; Ohta K; Kasahara Y; Yachie A
Rheumatology (Oxford); 2010 Sep; 49(9):1645-53. PubMed ID: 20472718
[TBL] [Abstract][Full Text] [Related]
2. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Ko G; Saikawa Y; Kubota T; Yamasaki Y; Takei S; Yachie A
Clin Immunol; 2015 Oct; 160(2):277-81. PubMed ID: 26101092
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis.
Vastert SJ; van Wijk R; D'Urbano LE; de Vooght KM; de Jager W; Ravelli A; Magni-Manzoni S; Insalaco A; Cortis E; van Solinge WW; Prakken BJ; Wulffraat NM; de Benedetti F; Kuis W
Rheumatology (Oxford); 2010 Mar; 49(3):441-9. PubMed ID: 20019066
[TBL] [Abstract][Full Text] [Related]
5. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
[TBL] [Abstract][Full Text] [Related]
6. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.
de Jager W; Vastert SJ; Beekman JM; Wulffraat NM; Kuis W; Coffer PJ; Prakken BJ
Arthritis Rheum; 2009 Sep; 60(9):2782-93. PubMed ID: 19714583
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
8. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis.
Yanagimachi M; Naruto T; Miyamae T; Hara T; Kikuchi M; Hara R; Imagawa T; Mori M; Sato H; Goto H; Yokota S
J Rheumatol; 2011 Apr; 38(4):769-74. PubMed ID: 21239750
[TBL] [Abstract][Full Text] [Related]
9. Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome.
Maeno N; Takei S; Imanaka H; Yamamoto K; Kuriwaki K; Kawano Y; Oda H
Arthritis Rheum; 2004 Jun; 50(6):1935-8. PubMed ID: 15188370
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome.
Fall N; Barnes M; Thornton S; Luyrink L; Olson J; Ilowite NT; Gottlieb BS; Griffin T; Sherry DD; Thompson S; Glass DN; Colbert RA; Grom AA
Arthritis Rheum; 2007 Nov; 56(11):3793-804. PubMed ID: 17968951
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis.
Lotito AP; Campa A; Silva CA; Kiss MH; Mello SB
J Rheumatol; 2007 Apr; 34(4):823-30. PubMed ID: 17343316
[TBL] [Abstract][Full Text] [Related]
12. Recognition and management of macrophage activation syndrome in juvenile arthritis.
Kelly A; Ramanan AV
Curr Opin Rheumatol; 2007 Sep; 19(5):477-81. PubMed ID: 17762614
[TBL] [Abstract][Full Text] [Related]
13. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis.
Frosch M; Ahlmann M; Vogl T; Wittkowski H; Wulffraat N; Foell D; Roth J
Arthritis Rheum; 2009 Mar; 60(3):883-91. PubMed ID: 19248102
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation syndrome in juvenile idiopathic arthritis.
Cortis E; Insalaco A
Acta Paediatr Suppl; 2006 Jul; 95(452):38-41. PubMed ID: 16801165
[TBL] [Abstract][Full Text] [Related]
15. Recurrent macrophage activation syndrome associated with heterozygous perforin W374X gene mutation in a child with systemic juvenile idiopathic arthritis.
Unal S; Balta G; Okur H; Aytac S; Cetin M; Gumruk F; Ozen S; Gurgey A
J Pediatr Hematol Oncol; 2013 Jul; 35(5):e205-8. PubMed ID: 23274377
[TBL] [Abstract][Full Text] [Related]
16. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Davì S; Consolaro A; Guseinova D; Pistorio A; Ruperto N; Martini A; Cron RQ; Ravelli A;
J Rheumatol; 2011 Apr; 38(4):764-8. PubMed ID: 21285158
[TBL] [Abstract][Full Text] [Related]
17. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
[TBL] [Abstract][Full Text] [Related]
18. Acute liver failure in young children with systemic-onset juvenile idiopathic arthritis without macrophage activation syndrome: report of two cases.
Hiejima E; Komatsu H; Takeda Y; Sogo T; Inui A; Okafuji I; Nishikomori R; Nakahata T; Fujisawa T
J Paediatr Child Health; 2012 Mar; 48(3):E122-5. PubMed ID: 22050445
[TBL] [Abstract][Full Text] [Related]
19. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles.
Shimizu M; Nakagishi Y; Yachie A
Cytokine; 2013 Feb; 61(2):345-8. PubMed ID: 23276493
[TBL] [Abstract][Full Text] [Related]
20. Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Rosenblum ND; Feldman BM; Laxer RM; Schneider R
J Rheumatol; 2004 Oct; 31(10):2068-70. PubMed ID: 15468377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]